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Abstract
Human bocavirus 1 (HBoV1) has been identified as one of the etiological agents of wheezing in young children with acute
respiratory-tract infections. In this study, we have obtained the sequence of a full-length HBoV1 genome (including both
termini) using viral DNA extracted from a nasopharyngeal aspirate of an infected patient, cloned the full-length HBoV1
genome, and demonstrated DNA replication, encapsidation of the ssDNA genome, and release of the HBoV1 virions from
human embryonic kidney 293 cells. The HBoV1 virions generated from this cell line-based production system exhibits a
typical icosahedral structure of approximately 26 nm in diameter, and is capable of productively infecting polarized primary
human airway epithelia (HAE) from the apical surface. Infected HAE showed hallmarks of lung airway-tract injury, including
disruption of the tight junction barrier, loss of cilia and epithelial cell hypertrophy. Notably, polarized HAE cultured from an
immortalized airway epithelial cell line, CuFi-8 (originally derived from a cystic fibrosis patient), also supported productive
infection of HBoV1. Thus, we have established a reverse genetics system and generated the first cell line-based culture
system for the study of HBoV1 infection, which will significantly advance the study of HBoV1 replication and pathogenesis.
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Introduction
Human bocavirus 1 (HBoV1) was initially identified in 2005, in
nasopharyngeal aspirates of patients with acute respiratory-tract
infections (ARTI) [1]. It was found to be associated with ARTI in
children, at a detection rate of 2–19% [2–5]. Three additional
human bocaviruses, HBoV2, 3 and 4, discovered in human stool
samples, have since been phylogenetically and serologically
characterized [6–9]. However, whether these are associated with
any diseases is currently unknown. HBoV1 is commonly detected
in association with other respiratory viruses, and is the fourth most
common respiratory virus (after respiratory syncytial virus (RSV),
adenovirus and rhinovirus) in infants less than 2 years of age who
are hospitalized for the treatment of acute wheezing [2,10–12].
Indeed, ARTI is one of the leading causes of hospitalization of
young children in developed countries [13,14]. Acute HBoV1
infection, diagnosed by a virus load of .104 genome copies (gc)/
ml in respiratory samples, viraemia, or by detection of HBoV1-
specific IgM or of an increase in the levels of IgG antibodies,
results in respiratory illness [2,15–20]. Recent descriptions of life-
threatening HBoV1 infections in pediatric patients in association
with high virus loads or diagnostic HBoV1-specific antibodies [21–
23], in addition to a recent longitudinal study of children from
infants to puberty, documenting a clear association of acute
primary HBoV1 infection with respiratory symptoms [24],
strongly support that HBoV1 is an etiological agent of both upper
and lower ARTI.
HBoV1 has been classified as a new member of the genus
Bocavirus of the family Parvoviridae [25], of which bovine parvovirus
(BPV1) and minute virus of canines (MVC) are the prototypes
[26,27]. In comparison with the BPV1 and MVC genomes, the
HBoV1 genome sequences obtained previously appeared to
exclude the two termini, and therefore, were incomplete [28].
However, sequencing of the head-to-tail junctions of HBoV1 and
HBoV3 ‘‘episomes,’’ which had been amplified in DNA samples
extracted from HBoV1-infected differentiated human epithelial
cells and from intestinal biopsies of HBoV3-infected patients,
respectively, revealed portions of the HBoV termini [29,30].
Notably, these sequences were conserved with the terminal
sequences of BPV1 and MVC [28].
In vitro HBoV1 infection has been reported only once in well-
differentiated human airway epithelia (HAE) [31]. That study
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provided only minimal information on virus replication, and did
not include observations of pathophysiology. Obviously, the lack
of a sustainable and highly reproducible system that enables high-
yield virus production, as well as the ability to conduct reverse
genetics is a significant barrier to further elucidation of HBoV1
replication and pathogenesis. In the current study, we have
successfully sequenced the full-length HBoV1 genome and cloned
it in a plasmid referred to as pIHBoV1. Furthermore, we have
demonstrated that transfection of human embryonic kidney 293
(HEK293) cells with pIHBoV1 results in efficient production of
HBoV1 virions at a high titer, and that these virions are able to
productively infect both primary and conditionally transformed
polarized HAE.
Results
The terminal hairpins of the HBoV1 genome are typical of
those of the genus Bocavirus
A head-to-tail junction of an HBoV1 episome identified in an
HBoV1-infected HAE [28,29] was found to possess two sequences
(39-CGCGCGTA-59 and 39-GATTAG-59) identical to parts of the
BPV1 left-end hairpin (LEH) [27,32]. This finding suggested that
the head sequence is part of the HBoV1 LEH (nucleotides in blue;
Figure 1A). We therefore used the head sequence as the 39 end of a
reverse primer (RHBoV1_LEH). Together with a forward primer
(FHBoV1_nt1), which anchors the 39 end of the HBoV1 genome
predicted from the BPV1 LEH, we amplified the hairpin of the
LEH from a viral DNA extract (1.26108 gc/ml) prepared from a
nasopharyngeal aspirate taken from an HBoV1-infected patient
(HBoV1 Salvador1 isolate) [17]. Only one specific DNA band was
detected at approximately (,)150-bp (Figure 1D, lane 1).
Sequencing of this DNA revealed a novel sequence of the HBoV1
LEH (nucleotides in red between the two arrows; Figures 1A and
S1A). Because the LEHs of the prototype bocaviruses BPV1 and
MVC are asymmetric [27,32], we set up another PCR reaction
with a forward primer located in the hairpin (FHBoV1_LEH) and
a reverse primer targeting a sequence downstream of the LEH at
nt 576 (RHBoV1_nt576; Figure 1B). Sequencing of a DNA
fragment (Figure S1B), detected as expected as a ,600-bp band
(Figure 1D, lane 3), confirmed the presence of the novel joint
sequence and the LEH (Figure 1B).
The tail of the HBoV1 head-to-tail junction [28,29] was found to
contain a sequence (59-GCG CCT TAG TTA TAT ATA ACA T-
39) identical to that of the right-end hairpin (REH) of the other
prototypic bocavirus MVC [27]. We thus speculated that the entire
HBoV1 REH is similar in structure to its MVC counterpart. Using
a reverse primer targeted to this sequence (RHBoV1_nt5464) and a
forward primer located upstream of the REH (FHBoV1_nt5201),
we were able to amplify a specific ,300-bp-long DNA fragment
(Figure 1D, lane 5). Sequencing confirmed the presence of the
palindromic hairpin of the predicted REH (nucleotides in red;
Figures 1C and S1C), and revealed two novel nucleotides at the end
of the hairpin (GC in red; Figure 1C).
These results indicate that we have identified, for the first time,
both the LEH and REH of the HBoV1 genome from a clinical
specimen, and confirm that the HBoV1 genome structure is
typical of the genus Bocavirus.
A full-length HBoV1 clone (pIHBoV1) is capable of
replicating and producing progeny virus in HEK293 cells
We also cloned and sequenced the non-structural (NS) and
capsid (VP) protein-coding (NSVP) genes of the HBoV1 Salvador1
isolate from the patient-extracted viral DNA. We then ligated the
LEH, NSVP genes and REH into pBBSmaI using strategies
diagramed in Figure S2, and refer to this full-length clone as
pIHBoV1. We have deposited the sequence of the full-length
genome of the isolate in GenBank (JQ923422).
As we previously showed that HEK293 cells support replication
of the DNA of an autonomous human parvovirus (B19V) in the
presence of adenovirus helper genes or adenovirus [33], we first
investigated whether the adenovirus helper function is necessary
for pIHBoV1 replication in HEK293 cells. Specifically, we
transfected pIHBoV1 into HEK293 cells (untreated or infected
with adenovirus), alone or with pHelper. Interestingly, we found
that pIHBoV1 replicated well in the absence of helper virus.
Indeed, all the three representative forms of replicated bocavirus
DNA [27,34] (DpnI digestion-resistant dRF DNA, mRF DNA and
ssDNA) were detected in each test case, and at similar levels
(Figure 2A). DpnI digestion-resistant DNA bands are newly
replicated DNA in cells as DpnI digestion only cleaves plasmid
DNA prepared from prokaryotic cells, which is methylated at the
dam site [35]. In contrast, these DNA forms of the viral genome
were absent in pIHBoV1-transfected primary airway epithelial
cells (NHBE; Figure 2B, lanes 7&8) and present at very low levels
(over 20 times lower than in pIHBoV1-transfected HEK293 cells)
in pIHBoV1-transfected human airway epithelial cell lines BEAS-
2B (Figure 2B, lanes 5&6), A549 and 16HBE14o- (Figure 2C),
even in the presence of adenovirus. Thus, replication in these cells
appears to be non-existent or poor in these contexts.
To confirm the specificity of DNA replication and the identity
of the DpnI-resistant DNA bands, we disrupted the ORFs
encoding viral proteins NS1, NP1, VP1 and VP2 in pIHBoV1;
knockout of expression of the corresponding viral protein was
confirmed by Western blot analysis. When the NS1 ORF was
disrupted, no DpnI digestion-resistant DNA was detected
(Figure 2D, lane 4), confirming that replication of this DNA
requires NS1. Notably, when the NP1 ORF was disrupted, an RF
DNA band was detected but it was very weak (Figure 2D, lane 6),
suggesting that NP1 is also involved. When the VP2 ORF was
knocked out, the ssDNA band disappeared, but this was not the
case when VP1 was disrupted (VP2 was still expressed; Figure 2D,
compare lanes 7 to 9), these findings are consistent with a role for
Author Summary
Human bocavirus 1 (HBoV1) has been identified as one of
the etiological agents of wheezing in young children with
acute respiratory-tract infections. HBoV1 productively
infects polarized primary human airway epithelia. Howev-
er, no cell lines permissive to HBoV1 infection have yet
been established. More importantly, the sequences at both
ends of the HBoV1 genome have remained unknown. We
have resolved both of these issues in this study. We have
sequenced a full-length HBoV1 genome and cloned it into
a plasmid. We further demonstrated that this HBoV1
plasmid replicated and produced viruses in human
embryonic kidney 293 cells. Infection of these HBoV1
progeny virions produced obvious cytopathogenic effects
in polarized human airway epithelia, which were repre-
sented by disruption of the epithelial barrier. Moreover, we
identified an airway epithelial cell line supporting HBoV1
infection, when it was polarized. This is the first study to
obtain the full-length HBoV1 genome, to demonstrate
pathogenesis of HBoV1 infection in human airway epithe-
lia, and to identify the first cell line to support productive
HBoV1 infection.
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the capsid formation in packaging of the parvoviral ssDNA
genome [36–38].
The presence of the ssDNA band in pIHBoV1-transfected
HEK293 cells suggested that progeny virions were produced. To
prove this, we carried out large-scale pIHBoV1 transfection and
CsCl equilibrium centrifugation to purify the virus that was
produced. We fractionated the CsCl gradient, and found the
highest HBoV1 gc (1–56108 gc/ml) at a density of 1.40 mg/ml,
which is typical of the parvovirus virion. Electron microscopy
analysis revealed that purified virus displayed a typical icosahedral
structure, with a diameter of ,26 nm (Figure 2E).
Collectively, these findings confirm that we have generated a
full-length clone of HBoV1 capable of replicating and producing
progeny virus in transfected HEK293 cells.
HBoV1 progeny virus produced from pIHBoV1-
transfected cells is infectious
The infectivity of the HBoV1 virions purified from pIHBoV1-
transfected HEK293 cells was examined in polarized primary
HAE, the in vitro culture model known to be permissive to HBoV1
infection [31]. Three sets (different donors, culture lots #B29-11,
B31-11 and B33-11) of B-HAE were generated, and these were
Figure 1. Sequencing the terminal hairpins of the HBoV1 Salvador1 isolate. Sequence and predicted structure of the left-end, LEH (A&B),
and right-end, REH (C), hairpins are shown and diagramed, with PCR primers indicated by arrowed lines. PCR products were analyzed by
electrophoresis on 2% agarose gels; the expected DNA bands are indicated by arrowheads (D). In both the LEH and REH, nucleotides in red represent
new sequences identified in this study, nucleotides in blue represent sequences identified from the head-tail junction of an HBoV1 episome [28,29],
and nucleotides in black are the 59end and 39end sequences of the incomplete HBoV1 genome (GenBank: JQ411251).
doi:10.1371/journal.ppat.1002899.g001
Human Bocavirus Reverse Genetics System
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infected with HBoV1 from the apical side. Initially the B-HAE
cultures were infected with various amounts of virus, and when a
multiplicity of infection (MOI) of ,750 gc/cell was used, most of
the cells (,80%) were positive for anti-NS1 staining (indicating
that the viral genome had replicated and that genes encoded by it
had been expressed) at 5 days post-infection (p.i.). This MOI was
subsequently used for apical infection. Notably, B29-11, B31-11
and B33-11 HAE each supported productive HBoV1 infection
(Figures 3 and S3). Immunofluorescence (IF) analysis of infected
B31-11 HAE at 12 days p.i. showed that virtually all the cells
expressed NS1 and NP1 (Figures 3A and 3B), and that a good
portion of the infected cells expressed capsid proteins (VP1/2;
Figure 3C).
The production of progeny virus following HBoV1 infection
was monitored daily by collecting samples from both the apical
and basolateral chambers of the HAE culture and carrying out
Figure 2. Southern blot analysis of pIHBoV1 transfection and electron microscopy analysis of purified virus. (A–D) Southern blot
analysis. (A) HEK293 cells (plus or minus infection with adenovirus type 5 (Ad) at an MOI of 5) were transfected with pIHBoV1, alone or together with
pHelper, as indicated. (B&C) pIHBoV1 was transfected into various cell lines that had (+) or had not (2) been infected with Ad as indicated. Lanes 1–8
in panel B were analyzed on the same gel, and the gels shown in panels B&C were transferred and blotted together. Ten ng of the HBoV1 dsDNA
genome (,5.6-kb), excised from pIHBoV1 using the SalI and XhoI sites, was used as a control (Ctrl) for DpnI digestion in panels A–C. (D) HEK293 cells
were transfected with pIHBoV1 and its various mutants as indicated. At 48 h post-transfection, Hirt DNA was extracted and digested with (+) or
without (2) DpnI, followed by Southern blotting using the HBoV1 dsDNA genome as a probe. dRF DNA, double replicative form DNA; mRF DNA,
monomer replicative form DNA. (E) Negative staining electron micrograph. Purified HBoV1 particles were negatively stained and examined by a
transmission electron microscopy. Bar indicates 100-nm.
doi:10.1371/journal.ppat.1002899.g002
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HBoV1-specific quantitative PCR (qPCR; Figures 4A and S3B).
In the case of B33-11 B-HAE, apical release was obviously
initiated at 3 days p.i., then continued to increase to a peak of
,108 gc/ml at 5–7 days p.i., then decreased slightly through day
10 p.i. and was maintained at a level of ,107 gc/ml through day
22 p.i. (Figure 4A). The total virus yield from one Millicell insert of
0.6 cm2 over a 24-h interval was greater than 261010 gc. This
result suggested that productive HBoV1 infection of primary B-
HAE is persistent. Notably, in the B-HAE cultures from both
donors, virus was also continuously released from the basolateral
side, keeping pace with apical secretion throughout, though at
levels about one log lower than the release from the apical surface
(Figures 4A and S3B). The genomes of the progeny virions
released from infected B-HAE were amplified and sequenced
using the primers listed in Figure 1 and primers spanning the
NSVP genes between the termini. The result showed an identical
sequence with that of the HBoV1 Salvador isolate (Genbank
JQ923422). Additionally, no virus was detected in mock-infected
B-HAE (data not shown).
Taken together, these results demonstrate that the HBoV1
virions produced by pIHBoV1 transfection is capable of infecting
polarized primary HAE cultures from cells derived from various
donors and releasing identical progeny virions from infected
primary HAE. More importantly, we found that productive
HBoV1 infection was persistent.
HBoV1 infection of primary B-HAE features characteristics
of respiratory-tract injury
Although no gross cytopathic effects were observed in HBoV1-
infected B-HAE, histology analysis of mock- vs. HBoV1-infected
epithelia (B33-11) revealed morphological differences: infected B-
HAE did not feature obvious cilia at 7 days p.i., and was
significantly thinner than the mock-infected one on average at 22
days p.i. (Figure 4B). We further monitored the transepithelial
electrical resistance (TEER) during infection of B-HAE, and found
that at 6 days p.i., it was reduced from a value of ,1,200 to
,400 V.cm2, while the mock-infected B-HAE maintained the
initial TEER (Figure 4C). Notably, the decrease in TEER in the
infected B-HAE was accompanied by an increase in HBoV1
secretion (Figure 4A).
To confirm a role for HBoV1 infection in disruption of the
barrier function of the epithelium, we examined the distribution of
the tight junction protein Zona occludens-1 (ZO-1) [39]. Infected
B-HAE showed dissociation of ZO-1 from the periphery of cells
started from 7 days p.i., compared with mock-infected B-HAE
(Figure 5A), which likely plays a role in reducing TEER.
Cumulatively, these results demonstrate that HBoV1 infection
disrupts the integrity of HAE and that this may involve breakdown
of polarity and redistribution of the tight junction protein ZO-1.
To confirm a role for HBoV1 infection in the loss of cilia, we
examined expression of the b-tubulin IV, which is a marker of cilia
[40,41]. In HBoV1-infected B-HAE, expression of b-tubulin IV
was drastically decreased at 7 days p.i., and was not detected at 22
days p.i., in contrast to that in mock-infected B-HAE (Figure 5B).
These results confirmed that HBoV1 infection caused the loss of
cilia in infected B-HAE. Notably, infected B-HAE showed changes
of nuclear enlargement, which became obvious at 22 days p.i.
(Figure 5, DAPI), indicating airway epithelial cell hypertrophy.
Collectively, we found that productive HBoV1 infection
disrupted the tight junction barrier, lead to the loss of cilia and
airway epithelial cell hypertrophy. These are hallmarks of
respiratory tract injury when a loss of epithelial cell polarity occurs.
An immortalized human airway epithelial cell line
supports HBoV1 infection when the cells are polarized
Although primary HAE cultures support HBoV1 infection,
their usefulness is limited by the variability between donors, tissue
availability and high cost. We thus explored alternative cell culture
models for their abilities to support HBoV1 infection. Using the
Figure 3. Transfection-produced HBoV1 infects primary B-HAE.
The primary B-HAE (B31-11) was cultured in Millicell inserts, and
infected with purified HBoV1 at the apical surface. At 12 days post-
infection (p.i.), mock- and HBoV1-infected primary B-HAE cultures were
fixed and analyzed by immunofluorescence (IF) using anti-(HBoV1) NS1
(A), NP1 (B), and VP1/2 (C) as indicated. Nuclei were stained with 49,6-
diamidino-2-phenylindole (DAPI; blue) and cells were visualized by
confocal microscopy at a magnification of 640. HAE, human airway
epithelia.
doi:10.1371/journal.ppat.1002899.g003
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purified HBoV1, we examined HEK293 cells, other common
epithelial cell lines permissive to common respiratory viruses [42],
including HeLa, MDCK, MRC-5, LLC-MK2 and Vero-E6, and
several transformed or immortalized human airway epithelial cell
lines (A549, BEAS-2B, 16HBE14o- [43], NuLi-1 and CuFi-8
[44]), as well as primary NHBE cells for the ability to support
Figure 4. HBoV1 infection of primary B-HAE is persistent and causes cytopathogenic effects. The primary B-HAE (B33-11) was cultured in
Millicell inserts, and infected with HBoV1 at the apical surface. (A) At the indicated days p.i., the apical surface was washed with 200 ml of PBS to
remove released virus. 50 ml of the medium were taken from the basolateral side. DNase-resistant HBoV1 DNA copies were quantified by qPCR (y-axis)
and plotted to the days p.i. as shown. Averages and standard deviations are shown. (B) At 7 and 22 days p.i., HBoV1-infected primary B-HAE
membranes taken from the bottom of the inserts were embedded in OCT, sectioned, and stained using hematoxylin and eosin. Mock-infected B-HAE
was taken at 22 days p.i. Images were taken at a magnification of660. (C) The transepithelial electrical resistance (TEER) of mock- and HBoV1-infected
primary B-HAEs was measured using an epithelial Volt-Ohm Meter (Millipore) at the indicated days p.i. Averages and standard deviations are shown.
doi:10.1371/journal.ppat.1002899.g004
Human Bocavirus Reverse Genetics System
PLOS Pathogens | www.plospathogens.org 6 August 2012 | Volume 8 | Issue 8 | e1002899
infection in conventional monolayer culture. All were negative for
HBoV1 infection as determined by IF analysis (data not shown).
We next speculated that since some respiratory viruses infect
polarized HAE but not undifferentiated cells [45], some charac-
teristics of the polarized epithelia may be critical for HBoV1
infection. We thus polarized immortalized cells (NuLi-1 and CuFi-
Figure 5. IF analysis of the tight junction protein ZO-1 and the cilia marker b-tubulin IV during HBoV1 infection of primary B-HAE.
Mock- and HBoV1-infected B-HAE (B33-11) cultures at the indicated days p.i. were co-stained with anti-NS1 and anti-ZO-1 (Invitrogen) antibodies (A),
or co-stained with anti-(HBoV1) NS1 and anti-b-tubulin IV (Sigma) antibodies (B). Confocal images were taken at a magnification of 640. Nuclei were
stained with DAPI (blue).
doi:10.1371/journal.ppat.1002899.g005
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8) at an air-liquid interface (ALI) for one month. Once polarization
was confirmed by detection of a TEER of .500 V.cm2, the
cultures were infected with HBoV1, under the same conditions as
used for primary B-HAE cultures. Notably, IF analysis revealed
that at 10 days p.i., HBoV1-infected CuFi-HAE (differentiated
from CuFi-8 cells) was uniformly positive for NS1 (Figure 6A),
whereas the HBoV1-infected NuLi-HAE (differentiated from
NuLi-1 cells) was not (Figure S4). Moreover, the CuFi-HAE did
express HBoV1 NS1, NP1 and VP1/VP2 proteins (Figures 6B and
6C). The kinetics of virus release from the apical surface was
similar to that of a primary B-HAE infected with virus at a similar
titer (maximally 26107 gc/ml), although virus release from the
basolateral surface was undetectable (Figure 6D). HBoV1 infection
also resulted in a decrease in the thickness of the epithelium
(Figure 6E), and dissociation of the tight junction protein ZO-1
from the epithelial cell peripheries (Figure 6F).
Collectively, these findings demonstrate that the immortalized
cell line CuFi-8 [44], when cultured and polarized at an ALI,
supports HBoV1 infection, and recapitulates the infection
phenotypes observed in primary HAE, including destruction of
the airway epithelial structure.
Discussion
In this study, we have cloned the full-length HBoV1 genome
and identified its terminal hairpins. Virions produced from
transfection of this clone into HEK293 cells are capable of
infecting polarized HAE cultures. Thus, we have established a
reverse genetics system that overcomes the critical barriers to
studying the molecular biology and pathogenesis of HBoV1, using
an in vitro culture model system of HAE.
It is notable that the HBoV1 terminal hairpins appear to be
hybrid relicts of the prototype bocavirus BPV1 at the LEH, but of
MVC at the REH [28]. Replication of HBoV1 DNA in HEK293
cells revealed typical replicative intermediates of parvoviral DNA.
Although the head-tail junctions are unexpected in the replication
of autonomous parvoviruses, they were likely generated during the
cycle of rolling hairpin-dependent DNA replication [46]. There-
fore, we believe that the replication of HBoV1 DNA basically
follows the model of rolling hairpin-dependent DNA replication of
autonomous parvoviruses, with terminal and junction resolutions
at the REH and LEH, respectively [46]. The replication of
parvoviral DNA depends on entry into S phase of the cell cycle or
the presence of helper viruses [46,47]. In this regard, it is puzzling
that mature, uninjured airway epithelia are mitotically quiescent
(,1% of cells dividing) [48–50], as are the majority of the cells in
polarized HAE (in the G0 phase of the cell cycle). However,
recombinant adeno-associated virus (AAV; in genus Dependovirus of
the family of Parvoviridae) infects HAE apically and expresses
reporter genes [51–53]. Gene expression by recombinant AAV
requires a conversion of the ssDNA viral genome to a double-
stranded DNA form that is capable to be transcribed [54]. This
conversion involves DNA synthesis. Hence, we hypothesize that
HBoV1 employs a similar approach to synthesize its replicative
form DNA. Notably, wild type AAV infected primary HAE
apically and replicated when adenovirus was co-infected [55]. The
exact mechanism of how HBoV1 replicates in normal HAE will be
an interesting topic for further investigation.
The airway epithelium, a ciliated pseudo-stratified columnar
epithelium, represents the first barrier against inhaled microbes
and actively prevents the entry of respiratory pathogens. It consists
of ciliated cells, basal cells and secretory goblet cells that together
with the mucosal immune system, provide local defense mecha-
nisms for the mucociliary clearance of inhaled microorganisms
[56]. The polarized ciliated primary HAE, which is generated by
growing isolated tracheobronchial epithelial cells at an ALI for on
average one month, forms a pseudo-stratified, mucociliary
epithelium and displays morphologic and phenotypic character-
istics resembling those of the in vivo human cartilaginous airway
epithelium of the lung [57,58]. Recent studies have revealed that
this model system recapitulates important characteristics of
interactions between respiratory viruses and their host cells
[41,45,59–62].
In the current study, we have examined primary B-HAE
cultures obtained from three different donors. HBoV1 infection of
primary B-HAE was persistent and caused morphological changes
of the epithelia, i.e. disruption of the tight barrier junctions, loss of
cilia and epithelial cell hypertrophy. The loss of the former, plasma
membrane structures that seal the perimeters of the polarized
epithelial cells of the monolayer, is known to damage the cell
barrier necessary to maintain vectorial secretion, absorption and
transport. ZO-1, which we monitored here, is specifically
associated with the tight junctions and remains the standard
marker for these structures. Similarly, cilia play important roles in
airway epithelia, in that they drive inhaled particles that adhere to
mucus secreted by goblet cells outward [63]. HBoV1 infection
compromises barrier function, and thus potentially increases
permeability of the airway epithelia to allergens and susceptibility
to secondary infections by microbes. The observed shedding of
virus from the basolateral surface of infected primary HAE, albeit
at a lower level (,1 log lower than that from the apical surface), is
consistent with the facts that HBoV1 infection disrupted the
polarity of the pseudo-stratified epithelial barrier and resulted in
the leakage to the basolateral chamber. This explanation is also
supported by HBoV1 infection of CuFi-HAE, where disruption of
the tight junction structure was less severe and virus was released
only from the apical membrane. The induction of leakage by
HBoV1 also suggests a mechanism that accounts for the viraemia
observed in HBoV1-infected patients [5]. Further disease pathol-
ogy could be accounted for by infection-induced loss of cilia of the
airway epithelia; a lack of cilia is often responsible for bronchiolitis
[64–66]. Therefore, our study provides direct evidence that
HBoV1 is pathogenic to polarized HAE, which serves as in vitro
model of the lung [57,58]. Since HBoV1 is frequently detected
with other respiratory viruses in infants hospitalized for acute
wheezing [2,10–12], the apparent pathological changes observed
in HBoV1-infected HAE suggest that prior-infection of HBoV1
likely facilitates the progression of co-infection-driven pathogenesis
in the patient.
The kinetics of virus release from the apical chamber of HAE
infected with the progeny virus of pIHBoV1 (cloned from the
clinical Salvador1 isolate) was similar to that following infection
with the HBoV1 Bonn1 isolate, a clinical specimen [31]. We
believe that our study of HBoV1 infection of primary HAE
reproduces infection of the virus from clinical specimens. In
addition, we generated virus from a pIHBoV1-b clone, which
contains the NSVP genes from the prototype HBoV1 st2 isolate
[1]. Infection of primary B-HAE with this st2 virus resulted in a
level of virus production similar to that observed here using the
Salvador1 isolate (data not shown). We believe that our study with
the laboratory-produced HBoV1 Salvador1 represents infection of
HBoV1 of clinical specimens in HAE. The MOI used for infection
in the current study was high. However, it should be noted that
this titer is based on the physical numbers of virion particles as
there are no practical methods for determining the infectious titer
of HBoV1 preparations. It should also be taken into consideration
that extensive parvovirus inactivation occurs during the purifica-
tion process, i.e. during CsCl equilibrium ultracentrifugation [67].
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Figure 6. Analyses of HBoV1-infected CuFi-HAE. (A) At 10 days p.i., mock- and HBoV1-infected CuFi-HAEs were analyzed by IF with an anti-
(HBoV1)NS1 antibody. (B&C) At 5 days p.i., mock- and HBoV1-infected CuFi-HAEs were analyzed by Western blotting with anti-(HBoV1)NS1, NP1, and
VP1/2 antibodies as indicated. pIHBoV1-transfected HEK293 cells were used as controls. (B) The blot was reprobed sequentially with anti-NP1 and
anti-b-actin antibodies; (C) the same samples were separated and blotted with the anti-b-actin antibody. Diamonds indicate specific viral proteins
detected, and the sizes of the marker are shown. (D) CuFi-HAE was infected with HBoV1, virus was collected from both the apical and basolateral
sides at days p.i. as indicated, and quantified. Averages and standard deviations are shown. (E) At 10 days p.i., mock- and HBoV1-infected CuFi-HAE
membranes were stained with hematoxylin and eosin. Images were taken at a magnification of 660. (F) At 10 days p.i., mock- and HBoV1-infected
CuFi-HAEs were analyzed by IF with an anti-ZO-1 antibody (BD Bioscience). Nuclei were stained with DAPI. Confocal images in panels A and F were
taken at a magnification of 640.
doi:10.1371/journal.ppat.1002899.g006
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Virus infection of HAE most likely reflects HBoV1 infection of the
lung airways in patients with a high virus load in respiratory
secretions [5].
The fact that pIHBoV1 did not replicate well in undifferentiated
human airway epithelial cells (Figures 2B and 2C) indicates that
polarization and differentiation of the HAE is critical for HBoV1
DNA replication. Nevertheless, polarized NuLi-HAE, which is
derived from normal human airway epithelial cells, did not
support HBoV1 infection, but the CuFi-HAE derived from airway
epithelial cells isolated from a cystic fibrosis patient did. The CuFi-
HAE is unique relative to the others in that it retains the capacity
to develop epithelia that actively transport in Na+ but not Cl2
because of the mutation in the cystic fibrosis gene [44]. Given the
high complexity of the airway epithelium, we speculate that the
permissiveness of HBoV1 infection is dependent on various steps
of virus infection, e.g. attachment, entry, intracellular trafficking,
and DNA replication of the virus. Nevertheless, a polarized CuFi-
HAE model derived from the CuFi-8 cell line represents a novel
stable cell culture model that is providing unexpected insights into
the infection characteristics of HBoV1. Although HBoV1 infection
of CuFi-HAE reproduced disruption of the barrier tight junctions
like that seen also in primary B-HAE, the absence of virus on the
basolateral side implies that in HAE the secretion of HBoV1 is
apically polarized. We speculate that the milder damage of tight
junctions in these cells might prevent virus release from the
basolateral side of infected CuFi-HAE. Further studies will focus
on understanding the permissiveness of CuFi-HAE to HBoV1
infection and on the reason for the ease of infection of an HAE
with a cystic fibrosis phenotype.
It has been shown that HBoV1 remains detectable in the upper
airways of patients for weeks and months, even up to half a year
[68–71]. However, the mechanism behind this persistence, i.e.
whether it is due to persistent replication and shedding, passive
persistence after primary infection, or recurrent mucosal surface
contamination, has remained unknown. Our results in in vitro HAE
cultures showed that HBoV1 is able to replicate and shed from
both the apical and basolateral surfaces at least for three weeks,
supporting the notion that shedding of the virus from the airways is
a long-lasting process. This may further explain why a high rate of
co-infection, or co-detection, between HBoV1 and other respira-
tory viruses has been reported [5]. Since recombinant AAV
persists as an episome in transduced tissues, which prolongs gene
expression [72,73], it is possible that also the HBoV1 genome can
be presented as an episome [29,30] for long term expression and
replication. Apparently, the mechanism underlying this feature of
HBoV1 infection warrants further investigation. However, in
contrast to the other human-pathogenic B19V, HBoV1 does not
seem to persist in human tissues for many years [74].
In conclusion, our findings indicate that the innovative reverse
genetics system for studying HBoV1 infection that we describe
here will enable us to elucidate the mechanism of HBoV1
replication and pathogenesis in a polarized HAE. Our system
mimics natural HBoV1 infection of the in vivo human cartilaginous
airway epithelia. The pathogenesis of HBoV1 in co-infection with
other respiratory viruses and in conditions of lung diseases is a
focus of future study.
Materials and Methods
Cell culture
Cell lines and primary cells. Human embryonic kidney
293 (HEK293) cells (CRL-1573), HeLa (CCL-2) , MDCK (CCL-
34), MRC-5 (CCL-171) , LLC-MK2 (CCL-7), and Vero-E6
(CRL-1586) were obtained from American Type Culture Collec-
tion (ATCC, Manassas, VA), and were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) with 10% fetal calf serum
(FCS). The cell lines originating from human airway epithelial cells
are A549 (ATCC CCL-185), BEAS-2B (ATCC CRL-9609),
16HBE14o- (obtained from Dr. Dieter Gruenert; [43]), as well
as NuLi-1 and CuFi-8 (Tissue and Cell Culture Core, Center for
Gene Therapy, University of Iowa). NuLi-1 and CuFi-8 were
immortalized from normal and cystic fibrosis human primary
airway cells, respectively, by expressing hTERT and HPV E6/E7
genes [44]. Primary Clonetics normal human bronchial/tracheal
epithelial cells (NHBE) were purchased from Lonza (Walkersville,
MD). Cells were cultured in media following instructions provided
by the supplier.
Human airway epithelium cultures. Polarized primary
HAE, termed as primary B-HAE, was generated by growing
isolated human airway (tracheobronchial) epithelial cells (three
HAE cultures were generated from different donors) on collagen-
coated, semipermeable membrane inserts (0.6 cm2, Millicell-PCF;
Millipore, Billerica, MA), and then allowing them to differentiate
at an air-liquid interface (ALI); this was carried out at the Tissue
and Cell Culture Core of the Center for Gene Therapy, University
of Iowa [44,58,75,76]. After 3–4 weeks of culture at an ALI, the
polarity of the HAE was determined based on the transepithelial
electrical resistance (TEER) using an epithelial Volt-Ohm Meter
(Millipore) and the relationship to infectability was assessed; a
value of over 1,000 V.cm2 was required for HBoV1 infection.
CuFi- and NuLi-HAE were generated following the same method
as above, but using the immortalized airway epithelial cell lines,
CuFi-8 and NuLi-1, respectively. The primary B-, CuFi-, and
NuLi-HAE were cultured, differentiated and maintained in
(50%:50%) DMEM:F12 medium containing 2% Ultroser G (Pall
BioSepra, Cergy-Staint-Christophe, France).
Isolation of virus and extraction of viral DNA
A nasopharyngeal aspirate was obtained from a child with
community-acquired pneumonia in Salvador, Brazil, who had an
acute HBoV1 infection (seroconversion, viraemia, and over 104 gc
of HBoV1 per ml of aspirate) [17]. Viral DNA was extracted
according to a method described previously [77].
Primers used and sequence amplification by the
Polymerase Chain Reaction (PCR)
The sequence of the head-to-tail junction of the HBoV1
episome suggests that HBoV LEH and REH share similarities
both in structure and sequence with that of the BPV LEH and
MVC REH, respectively [27,29]. Based on this information [28],
we designed primers to amplify the HBoV1 termini, which are
shown in Table 1 and Figure 1. The Phusion high fidelity PCR kit
(NEB, Ipswich, MA) was used following the manufactures’
instructions, to amplify the left-end hairpin (LEH) and the right-
end hairpin (REH) of HBoV1. Briefly, the DNA denaturation at
98uC for 30 s was followed by 35 cycles of: denaturing at 98uC for
10 s; annealing at 55uC for 15 s; and extension at 72uC for 30 s.
Following the final cycle, extension was continued at 72uC for
10 min. The PCR products were analyzed by electrophoresis in a
2% agarose gel. DNA bands were extracted using the QIAquick
gel extraction kit (Qiagen, Valencia, CA), and the extracted DNA
was directly sequenced at MCLAB (South San Francisco, CA),
using primers complementary to the extended sequences on the
forward and reverse amplification primers. PCR-generated DNA
was cloned in pGEM-T vector (Promega, Madison, WI), and
DNAs isolated from cultures of individual clones were subse-
quently sequenced.
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Construction of a full-length HBoV1 clone and its
mutants
Construction of the pBB vector. We first constructed a
pBBSmaI vector by inserting a linker of 59-SalI-SacII-KpnI-SmaI-
ApaI-SphI-KpnI-HindIII-XhoI-39 into a vector backbone
(pProEX HTb vector; Invitrogen) generated from the B19V
infectious clone pM20 [78] by removing all of the B19V sequence
(SalI-digestion). All cloning work was carried out in the Escherichia
coli strain of Sure 2 (Agilent, La Jolla, CA). All the nucleotide
numbers of HBoV1 refer to the HBoV1 full-length genome
(GenBank accession no.:JQ923422).
Cloning of the left-end hairpin (Figure S2B). The DNA
fragment SalI-BglII-nt93-518(BspEI)-576-XhoI-HindIII (contain-
ing the HBoV1 sequence nt 93–576), was amplified from the viral
DNA and inserted into SaII/HindIII-digested pBBSmaI, to
produce pBB2.1. Another DNA, SalI-nt1-86-BclI (containing
HBoV1 nt 1–86 sequence), was synthesized according to the
LEH sequence obtained in Figures 1A and 1B, and placed
between the SalI and BglII sites in pBB2.1, with ligation of the BclI
and BglII sites reproducing the HBoV1 sequence nt 87–92. The
resultant plasmid harboring the 59 HBoV1 nt 1–576 sequence
with an intact LEH is designated pBB-LEH.
Cloning of the right-end hairpin (Figure S2C). The DNA
fragment SalI-nt4097-4139(BglII)-5427(KasI)-ApaI (containing
the HBoV1 nt 4097–5427 sequence) was amplified from viral
DNA and inserted into SaII/ApaI-digested pBBSmaI, resulting in
pBB2.2. Another DNA fragment, ApaI-nt5460(KasI)-5543-XhoI
(containing HBoV1 nt 5460–5543 sequence) was synthesized
based on the REH sequence (Figure 1C) and placed between the
ApaI and HindIII sequences in pBB2.2, resulting in pBB-
REH(D5428–5459). The missing short fragment between the
two KasI sites encompassing nt 5428–5459 was recovered by a
synthesized KasI linker based on the REH sequence (Figure 1C)
and inserted into KasI-digested pBB-REH(D5428–5459). The
resultant plasmid harboring the 39 HBoV1 nt 4097–5543
sequence with an intact REH is designated pBB-REH.
Cloning of the pIHBoV1 (Figure S2D). The HBoV1 DNA
fragment SalI-nt1-518(BspEI)-576-XhoI, which was obtained from
SalI/XhoI-digestion of pBB-LEH, was ligated into SalI-digested
pBB-REH, resulting in pBB-LEH(BspEI/BglII)REH. The larger
fragment produced by digestion of this plasmid with BspEI/BglII
was ligated to the HBoV1 DNA fragment nt 518(BspEI)-
4139(BglII), which was amplified from the viral DNA. The final
construct containing the full-length HBoV1 (nt 1–5543) was
designated pIHBoV1.
Construction of pIHBoV1 mutants. pIHBoV1NS1(2) and
pIHBoV1NP1(2) were constructed by mutating HBoV1 nt 542
from T to A, and nt 2588 from G to A, resulting in stop codons
that lead to early termination of the NS1 and NP1 ORFs,
respectively. Similarly, pIHBoV1VP1(2) and pIHBoV1VP2(2)
were generated by mutating HBoV1 nt 3205 from T to A, and nt
3540 from T to G, disrupting VP1 and VP2 ORFs, respectively.
Transfection
Cells grown in 60-mm dishes were transfected with 2 mg of
plasmid as indicated in Figure 2; the Lipofectamine and Plus
reagents (Invitrogen/Life Technologies, Carlsbad, CA) were used
as previously described [79]. For some of the transfection
experiments, HEK293 cells were cotransfected with 2 mg of
pHelper plasmid (Agilent), which contains the adenovirus 5 (Ad5)
E2a, E4orf6, and VA genes, or infected with adenovirus type 5
(Ad) at an MOI of 5 as previously described [79].
Southern blot analysis
Low molecular weight (Hirt) DNA was extracted from
transfected cells, digested with DpnI (or left undigested) and
analyzed by Southern blotting as previously described [80].
Western blot analysis
Cells were lysed, separated by SDS-8% polyacrylamide gel
electrophoresis (PAGE), and blotted with antibodies as indicated
as previously described [81].
Production and purification of HBoV1
HEK293 cells were cultured on fifteen 150-mm plates in
DMEM-10%FCS, and transfected with 15 mg of pIHBoV1 per
dish using LipoD293 (SignaGen, Gaithersburg, MD). After being
maintained for 48 h at 5% CO2 and 37uC, the cells were collected,
resuspended in 10 ml of phosphate buffered saline, pH7.4 (PBS),
and lysed by subjecting them to four freezing (2196uC) and
thawing (37uC) cycles. The cell lysate was then spun at 10,000 rpm
for 30 min. The supernatant was collected and assessed on a
continuous CsCl gradient. In brief, the density was adjusted to
1.40 g/ml by adding CsCl, and the sample was loaded into an 11-
ml centrifuge tube and spun in a Sorvall TH641 rotor at
36,000 rpm, for 36 h at 20uC.
Fractions of 550 ml (20 fractions) were collected with a Piston
Gradient Fractionator (BioComp, Fredericton, NB, Canada), and
the density of each was determined by an Abbe’s Refractometer.
Viral DNA was extracted from each fraction and quantified with
respect to the number of HBoV1 gc, using HBoV1-specific qPCR
as described below. Those fractions containing the highest
numbers of HBoV1 gc were dialyzed against PBS, and then
viewed by electron microscope and used to infect HAE cultures.
Table 1. Sequences of PCR primers designed for amplifying the terminal hairpins of HBoV1.
Name Sequence (59-39)
FHBoV1_nt1 GTATTTTCAGGGCCTCGTCGACGTGGTTGTACAGACGCCATCTTG
RHBoV1_LEH GGAAGGCCTTGGATGTGGAAAGGCCGGATTAGATCATGCGCGC
FHBoV1_LEH CTAGGATCCGTATTTTCAGGGCCTCGTCGACTCAGTCATGCCTGCGCTG
RHBoV1_nt576 CGCAAGCTTCTCGAGTCTAGAAGCCCCAAAATGGCGATCTTCTAAAGA
FHBoV1_nt5201 CTAGGATCCGTTCCTCCTCAATGGACAAGCG
RHBoV1_nt5464 CACTGCAAGCTTGGAAGGCCTTGGATGTGGAAGCCGGCGCCTTAGTTATATAACAT
Note: Nucleotides underlined are HBoV1 sequences or sequences complementary to the HBoV1 sequence, and nucleotides shown in bold fonts are sequences
containing restriction enzyme sites and random sequences used to optimize PCR reactions and cloning.
doi:10.1371/journal.ppat.1002899.t001
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Observation by electron microscopy (EM)
The final purified virus preparation was concentrated by ,5-
fold, and adsorbed for 1 min on a 300-mesh copper EM grid
coated with a carbon film, followed by washing with deionized
water for 5 s and staining with 1% uranyl acetate for 1 min. The
grid was air dried, and was inspected on a 200 kV Tecnai F20 G2
transmission electron microscope equipped with a field emission
gun.
Virus infection
Fully differentiated primary B- (each of the three distinct
subtypes), CuFi- and NuLi-HAE were cultured in Millicell inserts
(0.6 cm2; Millipore) and inoculated with 150 ml of purified HBoV1
(16107 gc/ml in phosphate buffered saline, pH7.4; PBS) from the
apical surface (at a multiplicity of infection, MOI, of ,750 gc/cell;
an average of 26106 cells per insert). For each of the HAE, a 2-h
incubation was followed by aspiration of the virus from the apical
chamber and by three washes of the cells with 200 ml of PBS to
remove unbound virus. The HAEs were then further cultured at
an ALI.
For conventional monolayer cells, cells cultured in chamber
slides (Lab-Tek II; Nalge Nunc) were infected with purified
HBoV1 at an MOI of 1,000 gc/cell.
Immunofluorescence analysis
After HBoV1 infection, ALI membranes were fixed with 3.7%
paraformaldehyde in PBS at room temperature for 15 min. The
fixed membranes were cut into several small pieces, washed in PBS
three times for 5 min, and permeabilized with 0.2% Triton X-100
for 15 min at room temperature. The membranes were then
incubated with primary antibody at a dilution of 1:100 in PBS with
2% FCS for 1 h at 37uC. This was followed by incubation with a
fluorescein isothiocyanate- or rhodamine-conjugated secondary
antibody. Confocal images were taken with an Eclipse C1 Plus
confocal microscope (Nikon, Melville, NY) controlled by Nikon
EZ-C1 software. Primary antibodies used were anti-(HBoV1) NS1,
NP1 and VP1/2 antibodies, as reported previously [82].
For infected cells cultured in chamber slides, IF analysis was
carried out as previously described [83].
Quantitative PCR (qPCR) analysis
Virus samples were collected from both the apical and
basolateral surfaces at multiple time points. Apical washing and
harvesting was performed by adding 200 ml of PBS to the apical
chamber, incubating the samples for 10 min at 37uC and 5%
CO2, and removing and storing the 200 ml of PBS from the apical
chamber. Thereafter, 50 ml of medium were collected from each
basolateral chamber.
Aliquots (100 ml apical or 50 ml basolateral) of the samples were
incubated with 25 units of Benzonase (Sigma, St Louis, MO) for
2 h at 37uC, and then digested with 20 ml of proteinase K (15 mg/
ml) at 56uC for 10 min. Viral DNA was extracted using QIAamp
blood mini kit (Qiagen), and eluted in 100 ml or 50 ml of deionized
H2O. The extracted DNA was quantified with respect to the
number of HBoV1 gc, by a qPCR method that has been used
previously [84]. Briefly, the pskHBoV1 plasmid [82], which
contains the HBoV1 sequence (nt 1–5299), was used as a control (1
gc = 5.4610212 mg) to establish a standard curve for absolute
quantification with an Applied Biosystems 7500 Fast system
(Foster City, CA). The amplicon primers and the PrimeTime dual-
labeled probe were designed by Primer Express (version 2.0.0;
Applied Biosystems/Life Technologies) and synthesized at IDT
Inc. (Coralville, Iowa). Their sequences are as follows (GenBank:
JQ411251): forward primers, 59-GCA CAG CCA CGT GAC
GAA-39 (nt 2391 to 2408); reverse primer, 59-TGG ACT CCC
TTT TCT TTT GTA GGA-39 (nt 2466 to 2443); and PrimeTime
probe, 59 6FAM-TGA GCT CAG GGA ATA TGA AAG ACA
AGC ATC G-39 Iowa Black FQ (nt 2411 to 2441). Premix Ex Taq
(Takara Bio USA, Madison, WI) was used for qPCR following a
standard protocol. 2.5 ml of extracted DNA was used in a reaction
volume of 25 ml.
Histology analysis
On the last day of infection, the HAE on the Millicell inserts
were washed with PBS and fixed in 4% paraformaldehyde for
,30 min. The fixed membranes were cut into several small pieces,
and washed with PBS three times. Each membrane fragment was
transferred to 20% sucrose in a 15-ml conical tube and allowed to
drop to the bottom; it was then embedded vertically in
cryoprotectant OCT in an orientation that enabled sectioning of
the membrane perpendicular to the blade. Cryostat sections were
cut at a thickness of 10 mm, placed onto slides, and stained with
hematoxylin and eosin (H&E). Images were taken with a Nikon
80i fluorescence microscope at a magnification of 660.
Supporting Information
Figure S1 Sequencing of PCR DNA fragments. PCR DNA
fragments indicated by arrowheads in Figure 1D were extracted
and sequenced. A representative result of sequencing is shown in
each chromatogram. The sequences between the arrows in the
chromatograms (A–C) show the sequences which are complemen-
tary to those sequences between the arrows in the hairpin drawings
in Figure 1A–C, respectively.
(TIF)
Figure S2 Construction of a full-length pIHBoV1 clone.
(A) HBoV1 genome. The full-length genome of HBoV1 is
diagramed with structures of the left-end hairpin (LEH) and right-
end hairpin (REH) in a form of negative ssDNA from 39end to
59end. Restriction enzyme sites of BspEI and BglII in the
replicative form (RF) DNA are shown. (B) Cloning of the
LEH. PCR-amplified DNA fragments from the LEH, shown in
red, were ligated into pBBSmaI or its derivative. (C) Cloning of
the REH. PCR-amplified or synthesized HBoV1 DNA fragment
from the REH, shown in blue, were ligated into pBBSmaI or its
derivatives. (D) Cloning of the pIHBoV1. The pIHBoV1 was
constructed by ligating HBoV1 DNA nt 1–517 digested from pBB-
LEH and nt 518–4139 amplified from viral DNA extract (HBoV1
Salvador isolate) into the pBB-REH that contains HBoV1 REH
(nt 4140–5543). All the numbers are nucleotide numbers of the
HBoV1 genome (Genbank JQ923422).
(TIF)
Figure S3 Kinetics of virus release from HBoV1 infec-
tion of primary B31-11 and B29-11 HAE. Primary B-HAE
(donor B31-11 or B29-11) was infected with purified HBoV1 at an
MOI of ,750 genome copy numbers (gc)/cell. Virus was collected
from the apical chamber (A), or from both the apical and
basolateral chambers (B) for detection of nuclease-resistant viral
gc. Averages and standard deviations are shown. ND, not
determined.
(TIF)
Figure S4 Immunofluorescence analysis of HBoV1-
infected HAE polarized from NuLi-1 cells (NuLi-HAE).
NuLi-1 cells were polarized by growth at an ALI for 4 weeks on
Millicell inserts of 0.6 cm2, until a transepithelial electrical
resistance (TEER) of .500 V.cm2 was detected. Polarized HAE
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was infected with purified HBoV1 at an MOI of ,750 gc/cell. At
10 days p.i., infected NuLi-HAE was fixed and stained with an
anti-(HBoV1)NS1 antibody. Nuclei were stained with DAPI and
cells were visualized by confocal microscopy at a magnification of
640.
(TIF)
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